Inventor
JANNE PASI
US17 patents
⚠️ This page may combine multiple inventors who share the name “JANNE PASI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
16 patentsUS10385019B2Aug 20, 2019
Inhibitors of EGFR and methods of use thereof
DANA FARBER CANCER INST INC2 citations72
US10266517B2Apr 23, 2019
Pyrimidines as EGFR inhibitors and methods of treating disorders
DANA FARBER CANCER INST INC2 citations72
US10450310B2Oct 22, 2019
Bifunctional molecules for degradation of EGFR and methods of use
DANA FARBER CANCER INST INC5 citations71
US12331037B2Jun 17, 2025
Pyrimidines as EGFR-inhibitors and methods of treating disorders
DANA FARBER CANCER INST INC0 citations62
US11673882B2Jun 13, 2023
Pyrimidines as EGFR inhibitors and methods of treating disorders
DANA FARBER CANCER INST INC0 citations62
US10836722B2Nov 17, 2020
Inhibitors of EGFR and methods of use thereof
DANA FARBER CANCER INST INC1 citations62
US11858897B2Jan 2, 2024
Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK
DANA FARBER CANCER INST INC0 citations60
US11161842B2Nov 2, 2021
Bifunctional molecules for degradation of EGFR and methods of use
DANA FARBER CANCER INST INC0 citations60
US11066363B2Jul 20, 2021
Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK
DANA FARBER CANCER INST INC0 citations60
US11945816B2Apr 2, 2024
Inhibitors of EGFR and/or HER2 and methods of use
DANA FARBER CANCER INST INC0 citations58
US11186574B2Nov 30, 2021
Inhibitors of EGFR and/or HER2 and methods of use
DANA FARBER CANCER INST INC0 citations58
US10870636B2Dec 22, 2020
Pyrimidines as EGFR inhibitors and methods of treating disorders
DANA FARBER CANCER INST INC0 citations51
US10508082B2Dec 17, 2019
Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK
DANA FARBER CANCER INST INC0 citations51
US11814379B2Nov 14, 2023
Cyano quinoline amide compounds as HER2 inhibitors and methods of use
DANA FARBER CANCER INST INC0 citations50
US11584746B2Feb 21, 2023
Inhibitors of EGFR and methods of use thereof
DANA FARBER CANCER INST INC0 citations47
US10550112B2Feb 4, 2020
Pyrimidines as EGFR inhibitors and methods of treating disorders
DANA FARBER CANCER INST INC0 citations41